Pharming Group N.V. (PHAR) SEC Filings — 2024
19 SEC filings for Pharming Group N.V. (PHAR) in 2024.
Filings
- Pharming Group to Acquire NovaThera for $150M — 6-K · Dec 16, 2024
- Pharming Group's C1-INH Deficiency Drug Shows Positive Phase III Results — 6-K · Dec 11, 2024
- Pharming Group N.V. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Pharming Group N.V. SC 13G Filing — SC 13G · Nov 8, 2024
- Pharming Group N.V. Files Form 6-K — 6-K · Oct 24, 2024
- Pharming Group N.V. Files 6-K with Press Release — 6-K · Oct 10, 2024
- Pharming Group inks US marketing deal for RUCONEST® — 6-K · Sep 26, 2024
- Pharming Group N.V. Files 6-K with Press Release — 6-K · Aug 1, 2024
- Pharming Group N.V. Files 6-K with Press Release — 6-K · May 30, 2024
- Pharming Group N.V. Files Form 6-K — 6-K · May 21, 2024
- Pharming Group N.V. Files Form 6-K with Press Release — 6-K · May 15, 2024
- Pharming Group N.V. Files 6-K with Press Release — 6-K · May 8, 2024
- Pharming Group N.V. Files 6-K with April Press Releases — 6-K · Apr 25, 2024
- Pharming to Acquire Pharming Healthcare for $100M — 6-K · Apr 24, 2024
- Pharming Group N.V. Files 6-K with Press Release — 6-K · Apr 8, 2024
- Pharming Group N.V. Files 20-F Annual Report for Fiscal Year 2023 — 20-F · Apr 4, 2024
- Pharming Group N.V. Files 6-K for Q4 2023 Update — 6-K · Mar 14, 2024
- Pharming Group N.V. SC 13G Filing — SC 13G · Feb 14, 2024
- Pharming Ups 2023 Guidance: RUCONEST® Revenue Jumps 10%, Joenja® Hits $18M — 6-K · Jan 8, 2024